Ripening Interventions: Prostaglandins vs EASI Catheter
The RIPE Study: Ripening Interventions: Prostaglandins vs EASI Catheter
Sponsor: Loyola University
Listed as NCT00383942, this PHASE4 trial focuses on Cesarean Section and remains terminated or withdrawn. Sponsored by Loyola University, it has been updated 10 times since 2006, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Change History
10 versions recorded-
Sep 2024 — Present [monthly]
Terminated PHASE4
-
Jul 2024 — Sep 2024 [monthly]
Terminated PHASE4
-
Jan 2023 — Jul 2024 [monthly]
Terminated PHASE4
-
Dec 2022 — Jan 2023 [monthly]
Terminated PHASE4
-
Dec 2021 — Dec 2022 [monthly]
Terminated PHASE4
▶ Show 5 earlier versions
-
Jan 2021 — Dec 2021 [monthly]
Terminated PHASE4
-
Feb 2020 — Jan 2021 [monthly]
Terminated PHASE4
-
Jun 2018 — Feb 2020 [monthly]
Terminated PHASE4
-
May 2017 — Jun 2018 [monthly]
Terminated PHASE4
Phase: PHASE3 → PHASE4
-
Jan 2017 — May 2017 [monthly]
Terminated PHASE3
First recorded
Aug 2006
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Loyola University
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
- • Maywood, United States